BJU International

Cover image for Vol. 108 Issue 8b

October 2011

Volume 108, Issue 8b

Pages E164–E309

  1. Urological Oncology

    1. Top of page
    2. Urological Oncology
    1. Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging-targeted and systematic biopsy for significant prostate cancer detection (pages E171–E178)

      Jérémie Haffner, Laurent Lemaitre, Philippe Puech, Georges-Pascal Haber, Xavier Leroy, J. Stephen Jones and Arnauld Villers

      Article first published online: 22 MAR 2011 | DOI: 10.1111/j.1464-410X.2011.10112.x

    2. Incidence of prostate cancer in Sri Lanka using cancer registry data and comparisons with the incidence in South Asian men in England (pages E184–E189)

      Weranja K.B. Ranasinghe, Thabani Sibanda, M.V.C. de Silva, Tamra I.J. Ranasinghe and Raj Persad

      Article first published online: 25 MAR 2011 | DOI: 10.1111/j.1464-410X.2011.10165.x

    3. An analysis of world media reporting of two recent large randomized prospective trials investigating screening for prostate cancer (pages E190–E195)

      Nathan Lawrentschuk, Nikhil Daljeet, Greg Trottier, Phillip Crawley and Neil E. Fleshner

      Article first published online: 29 MAR 2011 | DOI: 10.1111/j.1464-410X.2010.09983.x

    4. Correlation of prostate-specific antigen nadir and biochemical failure after high-intensity focused ultrasound of localized prostate cancer based on the Stuttgart failure criteria – analysis from the @-Registry (pages E196–E201)

      Roman Ganzer, Cary N. Robertson, John F. Ward, Stephen C.W. Brown, Giario N. Conti, Francois J. Murat, Gilles Pasticier, Xavier Rebillard, Stefan Thuroff, Wolf F. Wieland and Andreas Blana

      Article first published online: 18 FEB 2011 | DOI: 10.1111/j.1464-410X.2011.10091.x

    5. Upgrade in Gleason score between prostate biopsies and pathology following radical prostatectomy significantly impacts upon the risk of biochemical recurrence (pages E202–E210)

      Niall M. Corcoran, Matthew K.H. Hong, Rowan G. Casey, Antonio Hurtado-Coll, Justin Peters, Laurence Harewood, S. Larry Goldenberg, Chris M. Hovens, Anthony J. Costello and Martin E. Gleave

      Article first published online: 28 MAR 2011 | DOI: 10.1111/j.1464-410X.2011.10119.x

    6. Effect of statin use on biochemical outcome following radical prostatectomy (pages E211–E216)

      Chad R. Ritch, Greg Hruby, Ketan K. Badani, Mitchell C. Benson and James M. McKiernan

      Article first published online: 31 MAR 2011 | DOI: 10.1111/j.1464-410X.2011.10159.x

    7. What is the best treatment strategy for incidentally detected small renal masses? A decision analysis (pages E223–E231)

      Robert Abouassaly, Simon Yang, Antonio Finelli, Girish S. Kulkarni and Shabbir M.H. Alibhai

      Article first published online: 13 MAY 2011 | DOI: 10.1111/j.1464-410X.2011.10115.x

    8. Comparison of radiographical imaging modalities for measuring the diameter of renal masses: is there a sizeable difference? (pages E232–E236)

      Phillip Mucksavage, Alexander Kutikov, Laurie Magerfleisch, Keith Van Arsdalen, Alan J. Wein, Parvati Ramchandani and S. Bruce Malkowicz

      Article first published online: 23 FEB 2011 | DOI: 10.1111/j.1464-410X.2010.09977.x

    9. Comparison of risk calculators from the Prostate Cancer Prevention Trial and the European Randomized Study of Screening for Prostate Cancer in a contemporary Canadian cohort (pages E237–E244)

      Greg Trottier, Monique J. Roobol, Nathan Lawrentschuk, Peter J. Boström, Kimberly A. Fernandes, Antonio Finelli, Karen Chadwick, Andrew Evans, Theodorus H. van der Kwast, Ants Toi, Alexandre R. Zlotta and Neil E. Fleshner

      Article first published online: 20 APR 2011 | DOI: 10.1111/j.1464-410X.2011.10207.x

    10. Addition of gemcitabine at the time of sunitinib resistance in metastatic renal cell cancer (pages E245–E249)

      Shuchi S. Pandya, James W. Mier, David F. McDermott and Daniel C. Cho

      Article first published online: 14 FEB 2011 | DOI: 10.1111/j.1464-410X.2011.10096.x

    11. Sequential use of sorafenib and sunitinib in advanced renal-cell carcinoma (RCC): an Italian multicentre retrospective analysis of 189 patient cases (pages E250–E257)

      Camillo Porta, Giuseppe Procopio, Giacomo Cartenì, Roberto Sabbatini, Alessandra Bearz, Isabella Chiappino, Enzo Maria Ruggeri, Giovanni Lo Re, Riccardo Ricotta, Fable Zustovich, Lorenza Landi, Anna Calcagno, Ilaria Imarisio, Elena Verzoni, Mimma Rizzo, Chiara Paglino, Valentina Guadalupi and Emilio Bajetta

      Article first published online: 23 MAY 2011 | DOI: 10.1111/j.1464-410X.2011.10186.x

    12. The volume–outcome relationship for radical cystectomy in England: an analysis of outcomes other than mortality (pages E258–E265)

      Erik K. Mayer, Alex Bottle, Paul Aylin, Ara W. Darzi, Thanos Athanasiou and Justin A. Vale

      Article first published online: 11 FEB 2011 | DOI: 10.1111/j.1464-410X.2010.10010.x

    13. Population-based analyses of radical cystectomy and urinary diversion for bladder cancer in northern Italy (pages E266–E271)

      Ugo Fedeli, Giacomo Novara, Claudia Galassi, Vincenzo Ficarra, Elena Schievano, Marco Gilardetti, Giovanni Muto, Oscar Bertetto, Giovannino Ciccone and Paolo Spolaore

      Article first published online: 14 FEB 2011 | DOI: 10.1111/j.1464-410X.2011.10095.x

    14. Regional lymph node status in patients with bladder cancer found to be pathological stage T0 at radical cystectomy following systemic chemotherapy (pages E272–E277)

      Matthew G. Kaag, Matthew I. Milowsky, Guido Dalbagni, R. Houston Thompson, Darren Katz, Victor E. Reuter, Harry W. Herr, Dean Bajorin and Bernard H. Bochner

      Article first published online: 14 FEB 2011 | DOI: 10.1111/j.1464-410X.2010.09981.x

    15. Multicenter evaluation of the prognostic value of pT0 stage after radical cystectomy due to urothelial carcinoma of the bladder (pages E278–E283)

      Matthias May, Patrick J. Bastian, Maximilian Burger, Christian Bolenz, Lutz Trojan, Edwin Herrmann, Christian Wülfing, Stefan C. Müller, Jörg Ellinger, Alexander Buchner, Christian G. Stief, Derya Tilki, Wolfgang Otto, Thomas Höfner, Markus Hohenfellner, Axel Haferkamp, Jan Roigas, Mario Zacharias, Wolf F. Wieland and Hans-Martin Fritsche

      Article first published online: 23 JUN 2011 | DOI: 10.1111/j.1464-410X.2011.10189.x

    16. Early vs delayed radical cystectomy for ‘high-risk’ carcinoma not invading bladder muscle: delay of cystectomy reduces cancer-specific survival (pages E284–E288)

      Wolfgang Jäger, Christian Thomas, Silke Haag, Christian Hampel, Alice Salzer, Joachim W. Thüroff and Christoph Wiesner

      Article first published online: 18 JAN 2011 | DOI: 10.1111/j.1464-410X.2010.09980.x

    17. Global histone H4K20 trimethylation predicts cancer-specific survival in patients with muscle-invasive bladder cancer (pages E290–E296)

      Ann-Christin Schneider, Lukas C. Heukamp, Sebastian Rogenhofer, Guido Fechner, Patrick J. Bastian, Alexander von Ruecker, Stefan C. Müller and Jörg Ellinger

      Article first published online: 31 MAY 2011 | DOI: 10.1111/j.1464-410X.2011.10203.x

    18. Racial differences in the outcome of patients with urothelial carcinoma of the upper urinary tract: an international study (pages E304–E309)

      Kazumasa Matsumoto, Giacomo Novara, Amit Gupta, Vitaly Margulis, Thomas J. Walton, Marco Roscigno, Casey Ng, Eiji Kikuchi, Richard Zigeuner, Wassim Kassouf, Hans-Martin Fritsche, Vincenzo Ficarra, Guido Martignoni, Stefan Tritschler, Joaquin Carballido Rodriguez, Christian Seitz, Alon Weizer, Mesut Remzi, Jay D. Raman, Christian Bolenz, Karim Bensalah, Theresa M. Koppie, Pierre I. Karakiewicz, Christopher G. Wood, Francesco Montorsi, Masatsugu Iwamura and Shahrokh F. Shariat

      Article first published online: 20 APR 2011 | DOI: 10.1111/j.1464-410X.2011.10188.x